Analysis of Factors Influencing the Interchangeability of Antiepileptic Drugs
- Авторы: Alyautdin R.N.1, Romanov B.K.1, Pasternak E.Y.1, Bunyatyan N.D.1, Merkulov V.A.1
- 
							Учреждения: 
							- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
 
- Выпуск: Том 50, № 3 (2016)
- Страницы: 181-184
- Раздел: Drugs
- URL: https://ogarev-online.ru/0091-150X/article/view/244339
- DOI: https://doi.org/10.1007/s11094-016-1418-x
- ID: 244339
Цитировать
Аннотация
The presence of several generics on the pharmaceutical market makes it possible to create a competitive environment and helps to reduce the costs of drug therapy. RF Government Decree No. 1154 of October 28, 2015, “On the procedure for determining the interchangeability of drugs for medical use” determines largely the fate of generics in Russia. Quality assurance of generics and the creation of a competitive environment for the procurement of pharmaceutical products by regional public health institutions in order to reduce costs were the primary drivers of this decree. However, results from substitution of antiepileptic drugs indicate a number of problems in this field. The present review is devoted to an analysis of the interchangeability problems of antiepileptic drugs.
Ключевые слова
Об авторах
R. Alyautdin
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
							Автор, ответственный за переписку.
							Email: alyautdin@mail.ru
				                					                																			                												                	Россия, 							Moscow, 127051						
B. Romanov
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: alyautdin@mail.ru
				                					                																			                												                	Россия, 							Moscow, 127051						
E. Pasternak
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: alyautdin@mail.ru
				                					                																			                												                	Россия, 							Moscow, 127051						
N. Bunyatyan
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: alyautdin@mail.ru
				                					                																			                												                	Россия, 							Moscow, 127051						
V. Merkulov
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: alyautdin@mail.ru
				                					                																			                												                	Россия, 							Moscow, 127051						
Дополнительные файлы
 
				
			 
						 
					 
						 
						 
						 
									 
  
  
  
  
  Отправить статью по E-mail
			Отправить статью по E-mail  Открытый доступ
		                                Открытый доступ Доступ предоставлен
						Доступ предоставлен Только для подписчиков
		                                		                                        Только для подписчиков
		                                					